Difference between revisions of "CD56"

From Libre Pathology
Jump to navigation Jump to search
(→‎Positive: +RCC occasionally)
Line 17: Line 17:
*[[Solid pseudopapillary tumour‎]].
*[[Solid pseudopapillary tumour‎]].
*[[Follicular dendritic cell sarcoma]].
*[[Follicular dendritic cell sarcoma]].
==Occasionally positive==
*[[Renal cell carcinoma]] ~18% of cases.<ref name=pmid20462442>{{cite journal |vauthors=Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P |title=Evaluation of neuroendocrine markers in renal cell carcinoma |journal=Diagn Pathol |volume=5 |issue= |pages=28 |date=May 2010 |pmid=20462442 |pmc=2876076 |doi=10.1186/1746-1596-5-28 |url=}}</ref>


==See also==
==See also==

Revision as of 13:24, 1 June 2020

CD56 is a commonly available immunostain that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation.

Positive

Carcinomas

Lymphoid

Others

Occasionally positive

See also

References

  1. Kurokawa, M.; Nabeshima, K.; Akiyama, Y.; Maeda, S.; Nishida, T.; Nakayama, F.; Amano, M.; Ogata, K. et al. (May 2003). "CD56: a useful marker for diagnosing Merkel cell carcinoma.". J Dermatol Sci 31 (3): 219-24. PMID 12727026.
  2. 2.0 2.1 URL: http://www.nordiqc.org/Epitopes/CD56/CD56.htm. Accessed on: September 13, 2014.
  3. Bahrami, A.; Gown, AM.; Baird, GS.; Hicks, MJ.; Folpe, AL. (Jul 2008). "Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.". Mod Pathol 21 (7): 795-806. doi:10.1038/modpathol.2008.86. PMID 18487991.
  4. "Evaluation of neuroendocrine markers in renal cell carcinoma". Diagn Pathol 5: 28. May 2010. doi:10.1186/1746-1596-5-28. PMC 2876076. PMID 20462442. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876076/.